Simple Summary Although it is one disease, cancer of the urinary bladder occurs in several
molecular subtypes that can be identified by laboratory tests. Tumors of advanced stages …

Despite an increased use of neoadjuvant and adjuvant chemotherapy, the long-term
survival rates after radical cystectomy or trimodal therapy (TMT) for muscle-invasive bladder …

Patients with high-risk renal cell carcinoma (RCC) experience high rates of recurrence
despite definitive surgical resection. Recent trials of adjuvant tyrosine kinase inhibitor …

AIM To develop and validate a radiomics-based model for predicting response to
neoadjuvant chemotherapy (NAC) using baseline computed tomography (CT) images in …

Objectives Neoadjuvant chemotherapy and radical cystectomy (RC) are underutilized
standards of care for the treatment of muscle-invasive bladder cancer (MIBC) due to high …

Objectives Prior studies have shown that pathologic complete response at radical
cystectomy, a significant prognostic factor, can be attributed to both neoadjuvant …

Purpose: The ideal number of neoadjuvant chemotherapy (NAC) cycles for muscle-invasive
bladder cancer is uncertain with 3 to 4 representing the standard of care (SOC). We …

Staging and reporting of cancers of the urinary tract have undergone major changes in the
past decade to meet the needs for improved patient management. Substantial progress has …

Purpose: While the presence of residual disease at the time of radical cystectomy for bladder
cancer is an established prognostic indicator, controversy remains regarding the importance …

Response classification after neoadjuvant chemotherapy in muscle-invasive bladder
carcinoma is based on the TNM stage at radical cystectomy. We recently showed that …